Company Disclosure

Key Transaction Details

  • Instrument: 19,51,000 Fully Convertible Equity Share Warrants
  • Conversion: Each warrant convertible into 1 equity share of ₹10 each
  • Issue Type: Preferential basis to promoters and non-promoters
  • Issue Price: Not less than ₹358 per warrant
  • Total Potential Equity: 19,51,000 equity shares upon full conversion

Regulatory Approvals Received

  • NSE Approval: Letter reference NSE/LIST/55077 dated August 07, 2026
  • BSE Approval: Letter reference LOD/PREF/SS/FIP/638/2026-27 dated August 07, 2026

Conditions for Approval

1. Filing listing application promptly after allotment

2. Obtaining all statutory approvals from SEBI, RBI, MCA, and other authorities

3. Compliance with all applicable guidelines, regulations, and directions

4. Compliance with SEBI (LODR) Regulations, 2015, Companies Act, and other laws

5. Submission of required documents and payment of applicable fees

Specific Compliance Requirements

  • The company must strengthen internal controls to monitor trades by proposed allottees
  • Must obtain undertaking from allottees confirming they will not engage in:
  • Intra-day trading in company scrip
  • Any sale in company scrip until allotment date
  • Responsibility for verification and compliance rests solely with the issuer company
  • Any non-compliance observed post-verification may impact listing of shares

Post-Allotment Requirements

  • Listing application must be filed within 20 days from date of allotment as per SEBI circular SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023
  • Non-compliance with listing application timeline will attract fines as specified in SEBI circular
  • For convertible securities, excess lock-in period of pre-preferential holding will be automatically released by depositories without requiring NOC from exchange

Important Caveats

  • In-principle approval does not constitute final listing approval
  • Exchange reserves right to withdraw approval if information is found incomplete/incorrect/misleading/false
  • Approval does not constitute approval under any other Act/Regulation/rule/bye-laws
  • Company must separately obtain approvals from other departments if required

Financial Impact

Financial impact not quantified in the disclosure. The potential equity dilution upon full conversion would be 19,51,000 shares, but the document does not provide current share capital or percentage dilution data.